Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Post by mramon Jan 20, 2021 7:02pm
103 Views
Post# 32340852

Juva's Strategy is in RESEARCH of MOLECULAR Formulations

Juva's Strategy is in RESEARCH of MOLECULAR Formulationsfrom Marijuana Plants.

The CEO & Founder ran his own DISPENSARY in Berkeley near San Francisco and he knows what the PATIENT's NEEDS are and that is the FOCUS of Juva Life. This is the reason for having Scientists and Doctors on board.

Our strategy integrates a path to sustainability and an ability to advance the development of novel formulations to address a myriad of unmet medical needs around the world.

A Different MJ play because of RESEARCH related to Pain/Cancer etc and many more derived products from MJ Plants for Doctors to prescribe to patients.


I am loving this company,do your DD before you buy,

<< Previous
Bullboard Posts
Next >>